Malignant Melanoma Clinical Trials

247 clinical trials for Malignant Melanoma across international registries, including 21 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 1 of CTX-8371 in Patients With Advanced Malignancies — RECRUITING · PHASE1
• Reducing Symptom Burden Through Physical Exercise in Melanoma Patients — RECRUITING · NA
• A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012) — RECRUITING · PHASE2
• A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer — RECRUITING · PHASE1
• An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors — RECRUITING · PHASE1
• Register for Cardiovascular Events under new cancer Therapies — RECRUITING
• Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC — RECRUITING · PHASE1
• FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis — RECRUITING · NA
• Modified Vaccine for High Risk or Low Residual Melanoma Patients — RECRUITING · PHASE1
• AMT-253 in Patients With Advanced Solid Tumours — RECRUITING · PHASE1
• Preoperative Planning With PSMA-PET in Melanoma Surgery Trial — RECRUITING · PHASE2
• Video-Tumorboard PLUS — RECRUITING
• RAPA-201 Therapy of Solid Tumors — RECRUITING · PHASE1
• Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary — RECRUITING
• A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma — RECRUITING · NA
• Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract — RECRUITING · NA
• GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors — RECRUITING · PHASE1
• Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies — RECRUITING · PHASE1
• Melanoma Metastasized to the Brain and Steroids — RECRUITING · PHASE2
• The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors — RECRUITING
• A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma — RECRUITING · PHASE2
• Cell based immune therapy for patients with skincancer — TERMINATED · PHASE2
• Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma — COMPLETED · PHASE1
• Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma — ACTIVE_NOT_RECRUITING · PHASE2
• INtra-tumor miCro dosIng in PatIents with advanced malignant mElanoma receiving aNti-PD1 Therapy. A pilot study. — TERMINATED · PHASE1
• GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 — TERMINATED · PHASE1
• Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis — ACTIVE_NOT_RECRUITING · PHASE2
• BEFAST STUDY: [68Ga]Ga-FAPI total body PET/CT for Better and Faster imaging in cancer [68Ga]Ga-FAPI PET/CT for response evaluation during immune checkpoint inhibitor therapy in malignant melanoma — TERMINATED · PHASE2
• A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies — TERMINATED · PHASE1
• Research on two creams (Monobenzon / Imiquimod) together with the standard treatment for advanced or metastatic melanoma (ImMI). — NOT_YET_RECRUITING · PHASE2
• Phase Ib of L-NMMA and Pembrolizumab — COMPLETED · PHASE1
• Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma — NOT_YET_RECRUITING · PHASE2
• A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors — TERMINATED · PHASE1
• Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma — COMPLETED
• IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma — COMPLETED · NA
• Retinal Structural and Functional Changes in Patients Treated With BRAF/MEK Inhibitors — COMPLETED · NA
• Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003) — COMPLETED · PHASE3
• A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors — TERMINATED · PHASE2
• A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) — TERMINATED · PHASE1
• Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension Study — COMPLETED · PHASE3
• SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study) — ACTIVE_NOT_RECRUITING · PHASE2
• Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma — ACTIVE_NOT_RECRUITING · PHASE1
• A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement — TERMINATED · PHASE1
• A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors — COMPLETED · PHASE1
• Study of IK-595 in RAS- or RAF-altered Advanced Tumors — TERMINATED · PHASE1
• A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma — TERMINATED · PHASE1
• Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma — TERMINATED · PHASE3
• Overcoming Primary Resistance to Immunotherapy in Metastatic Melanoma — COMPLETED · PHASE2

Refine this search